LOW-CALCIUM DIALYSATE STIMULATES PARATHORMONE SECRETION AND ITS LONG-TERM USE WORSENS SECONDARY HYPERPARATHYROIDISM

被引：0
作者：
FERNANDEZ, E
BORRAS, M
PAIS, B
MONTOLIU, J
机构：
[1] HOSP ARNAU DE VILANOVA,SERV NEPHROL,LLEIDA,SPAIN
[2] UNIV LLEIDA,DEPT MED & SURG,LLEIDA,SPAIN
来源：
KIDNEY INTERNATIONAL | 1995年 / 48卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 40 条
[21]   Long term culture of normal human breast cells in low-calcium, low-serum media allows for continuous secretion of native protein mammastatin [J].
Cankovic, M ;
Johnston, R ;
Ervin, PR .
FASEB JOURNAL, 2000, 14 (04) :A717-A717
[22]   EVALUATION OF HIGHLY BUFFERED LOW-CALCIUM SOLUTION FOR LONG-TERM PRESERVATION OF THE HEART - COMPARISON WITH UNIVERSITY-OF-WISCONSIN SOLUTION [J].
OHKADO, A ;
CAODANH, H ;
SOMMERS, KE ;
DELNIDO, PJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (04) :762-771
[23]   LONG-TERM EFFECT OF LOW CALCIUM DIALYSATE ON PARATHYROID ACTIVITY IN DIALYSIS PATIENTS TREATED WITH CALCIUM-CARBONATE AS A PHOSPHATE BINDER - REPLY [J].
SAWYER, N ;
NOONAN, K ;
ALTMANN, P ;
MARSH, F ;
CUNNINGHAM, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (08) :759-759
[24]   Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events [J].
Frampton, James E. .
DRUGS, 2015, 75 (07) :797-808
[25]   Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events [J].
James E. Frampton .
Drugs, 2015, 75 :797-808
[26]   Regulation of parathyroid hormone release by calcium before and after successful long-term calcitriol therapy in secondary hyperparathyroidism. [J].
Goodman, WG ;
Belin, T ;
Gales, B ;
Juppner, H ;
Segre, GV ;
Salusky, IB .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 :T451-T451
[27]   Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism [J].
Dorsch, Oliver .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) :637-640
[28]   Long-term effects of intravenous alpha(OH)D-3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis (vol 74, pg 89, 1996) [J].
Brandi, L .
NEPHRON, 1997, 77 (03) :353-353
[29]   Vorapaxar in the long-term secondary prevention of atherothrombotic events: a profile of its use in the USA [J].
McKeage K. ;
Lyseng-Williamson K.A. ;
Frampton J.E. .
Drugs & Therapy Perspectives, 2017, 33 (6) :254-259
[30]   CALCIUM-REGULATED PARATHYROID-HORMONE RELEASE BEFORE AND AFTER SUCCESSFUL LONG-TERM CALCITRIOL THERAPY IN SECONDARY HYPERPARATHYROIDISM [J].
GOODMAN, WG ;
BELIN, T ;
GALES, B ;
JUPPNER, H ;
SEGRE, GV ;
SALUSKY, IB .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03) :962-962
1234